Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (21-30 of 272) with videos related to

Pageof 28
Sort By:
Oncology Research and Treatment|June 5, 2016
Immunotherapy of MelanomaCarolin Bender, Jessica C Hassel, Alexander Enk
Life (Basel, Switzerland)|December 24, 2021
Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced MelanomaDevayani Machiraju, Sarah Schäfer, Jessica C Hassel
Cancers|October 14, 2022
Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous RituximabChristian Menzer, Adriana Rendon, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 17, 2023
Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinomaMartin Salzmann, Christoph Löser, Jessica C Hassel
Dermatologie (Heidelberg, Germany)|June 23, 2023
[Fertility preservation in patients with melanoma-a huge relief for those affected]Carola Berking, Jessica C Hassel, Elisabeth Livingstone
International Journal of Molecular Sciences|June 27, 2024
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic TargetsRobin Reschke, Alexander H Enk, Jessica C Hassel
Clinical Nuclear Medicine|November 7, 2015
18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With PembrolizumabChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss
American Journal of Clinical Dermatology|December 20, 2024
Prognostic Biomarkers in Evolving Melanoma ImmunotherapyRobin Reschke, Alexander H Enk, Jessica C Hassel
Signal Transduction and Targeted Therapy|April 10, 2025
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicitiesRobin Reschke, Alexander H Enk, Jessica C Hassel
Hellenic Journal of Nuclear Medicine|November 28, 2017
Metastatic melanoma response to combination therapy with ipilimumab and vemurafenibChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss
Pageof 28

Showing results (21-30 of 272) with videos related to

Sort By:
Pageof 28
Oncology Research and Treatment|June 5, 2016
Immunotherapy of MelanomaCarolin Bender, Jessica C Hassel, Alexander Enk
Life (Basel, Switzerland)|December 24, 2021
Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced MelanomaDevayani Machiraju, Sarah Schäfer, Jessica C Hassel
Cancers|October 14, 2022
Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous RituximabChristian Menzer, Adriana Rendon, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 17, 2023
Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinomaMartin Salzmann, Christoph Löser, Jessica C Hassel
Dermatologie (Heidelberg, Germany)|June 23, 2023
[Fertility preservation in patients with melanoma-a huge relief for those affected]Carola Berking, Jessica C Hassel, Elisabeth Livingstone
International Journal of Molecular Sciences|June 27, 2024
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic TargetsRobin Reschke, Alexander H Enk, Jessica C Hassel
Clinical Nuclear Medicine|November 7, 2015
18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With PembrolizumabChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss
American Journal of Clinical Dermatology|December 20, 2024
Prognostic Biomarkers in Evolving Melanoma ImmunotherapyRobin Reschke, Alexander H Enk, Jessica C Hassel
Signal Transduction and Targeted Therapy|April 10, 2025
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicitiesRobin Reschke, Alexander H Enk, Jessica C Hassel
Hellenic Journal of Nuclear Medicine|November 28, 2017
Metastatic melanoma response to combination therapy with ipilimumab and vemurafenibChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss
Pageof 28